Published in Eur Arch Psychiatry Clin Neurosci on February 17, 2009
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry (2011) 0.87
Twin-based study of the complex interplay between childhood maltreatment, socioeconomic status and adult memory. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
Perinatal complications in unaffected sisters of anorexia nervosa patients: testing a covariation model between genetic and environmental factors. Eur Arch Psychiatry Clin Neurosci (2010) 0.81
Combined visual and motor disorganization in patients with schizophrenia. Front Psychol (2013) 0.79
Exploratory factor structure of the neurological evaluation scale in black africans with first episode schizophrenia. Data Brief (2016) 0.78
Sensory and motor secondary symptoms as indicators of brain vulnerability. J Neurodev Disord (2013) 0.78
Schizophrenia: a systemic disorder. Clin Schizophr Relat Psychoses (2014) 0.77
Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States. J Nerv Ment Dis (2012) 0.77
Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development. J Psychiatry Neurosci (2017) 0.75
Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives. PeerJ (2016) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry (1994) 11.85
A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl (1970) 10.05
The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res (1989) 2.00
Neurological abnormalities in familial and sporadic schizophrenia. Brain (1998) 1.68
Neurological soft signs in schizophrenia. Br J Psychiatry (1990) 1.67
Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand (1999) 1.47
Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull (2005) 1.34
Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry (1995) 1.13
Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry (2003) 1.10
Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophr Res (2004) 1.02
Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res (2000) 1.02
Neurological soft signs in schizophrenia. Schizophr Res (1991) 1.01
Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry (2005) 1.00
Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry (2000) 0.99
Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci (2005) 0.97
Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance. Br J Psychiatry (1985) 0.97
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res (1999) 0.95
Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophr Res (2007) 0.95
Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry (2000) 0.95
Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Res (2003) 0.94
Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr Res (2002) 0.94
Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophr Res (2005) 0.91
Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry (1996) 0.91
Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res (1996) 0.90
Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry (2001) 0.89
The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Curr Opin Psychiatry (2005) 0.89
North African Berber and Arab influences in the western Mediterranean revealed by Y-chromosome DNA haplotypes. Hum Biol (2006) 0.88
Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci (1996) 0.88
Neurological abnormalities in schizophrenic patients and their siblings. Am J Psychiatry (1998) 0.86
Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophr Res (1998) 0.86
Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Mol Psychiatry (2002) 0.84
The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Res (2006) 0.84
The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry (1991) 0.82
Abnormal neurological signs at the onset of psychosis. Schizophr Res (2004) 0.81
Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Nerv Ment Dis (2000) 0.81
Neurological soft signs (NSS) in 200 treatment-naïve cases with schizophrenia: a community-based study in a rural setting. Nord J Psychiatry (2002) 0.80
Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry (1990) 0.80
[Neurological soft signs in schizophrenic patients and their nonaffected siblings]. Encephale (2008) 0.78
Factor structure of the Neurological Evaluation Scale in a predominantly African American sample of patients with schizophrenia, unaffected relatives, and non-psychiatric controls. Schizophr Res (2006) 0.78
Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients. Eur Arch Psychiatry Clin Neurosci (2006) 0.76
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Prevalence of smoking in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.17
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.04
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.04
Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res (2004) 1.01
Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med (2005) 0.98
Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia. Clin Neuropharmacol (2006) 0.97
Effect of cigarette smoking on plasma uric acid concentrations. Environ Health Prev Med (2010) 0.95
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) (2012) 0.94
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neuropsychopharmacol (2009) 0.88
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol (2004) 0.87
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry (2006) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res (2004) 0.86
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain (2013) 0.85
Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res (2005) 0.85
Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia. Psychiatry Res (2009) 0.84
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord (2011) 0.82
Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol (2009) 0.82
Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res (2009) 0.82
Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res (2010) 0.82
Nicotine use in schizophrenia and disinhibition. Psychiatry Res (2004) 0.82
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol (2009) 0.82
Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet (2008) 0.81
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet (2006) 0.81
The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord (2010) 0.81
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord (2008) 0.81
Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environ Health Prev Med (2011) 0.81
Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Res (2008) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
Deficit of inhibition motor control in untreated patients with schizophrenia: further support from visually guided saccade paradigms. Psychiatry Res (2010) 0.81
Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia (2010) 0.81
Association of the Met-196-Arg variation of human tumor necrosis factor receptor 2 (TNFR2) with paranoid schizophrenia. J Mol Neurosci (2010) 0.80
Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin Neurosci (2011) 0.80
Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil (2014) 0.80
Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol (2011) 0.80
Exploring and visualizing multidimensional data in translational research platforms. Brief Bioinform (2016) 0.79
Don't be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory. Front Behav Neurosci (2013) 0.79
Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res (2002) 0.79
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol (2010) 0.79
Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res (2010) 0.79
Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study. Neuropsychiatr Dis Treat (2010) 0.79
[Risk of hyperthyroidism in a Tunisian population of smokers]. Ann Biol Clin (Paris) (2012) 0.78
Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores. Psychiatry Res (2012) 0.78
Correlates between neurological soft signs and saccadic parameters in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.78
Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement. J Clin Exp Neuropsychol (2009) 0.78
Cannabis use and schizophrenia. Am J Psychiatry (2005) 0.78
Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci (2011) 0.78
Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr Res (2007) 0.78
A step toward an objective quantification of subtle neurological signs in schizophrenia. Psychiatry Res (2012) 0.78
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav Brain Funct (2013) 0.77
Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia. Front Psychiatry (2010) 0.77
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) (2007) 0.77
Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis. Eur Addict Res (2011) 0.77
Prevalence and score of minor physical anomalies in patients with schizophrenia and their first degree relatives: a Tunisian study. Compr Psychiatry (2013) 0.77
[Obesity and dyslipidemia in Tunisian bipolar subjects]. Ann Biol Clin (Paris) (2010) 0.77
Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights. World J Biol Psychiatry (2011) 0.77
Variable individual sensitivity to cannabis in patients with schizophrenia. Int J Neuropsychopharmacol (2010) 0.77